Verition Fund Management LLC Jounce Therapeutics, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
BUY
$6.37 - $10.33 $524,359 - $850,334
82,317 Added 91.0%
172,772 $1.21 Million
Q3 2020

Nov 16, 2020
BUY
$4.58 - $10.95 $414,283 - $990,482
90,455 New
90,455 $738,000
Q2 2020

Aug 14, 2020
SELL
$4.17 - $7.58 $611,372 - $1.11 Million
-146,612 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$2.91 - $8.7 $426,640 - $1.28 Million
146,612 New
146,612 $696,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email